CENGİZ SEVAL, G. Et Al. 2018. Ruxolitinib in steroid refractory GVHD treatment: single center experience. 44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) , (Lisbon, Portugal), 448-449.

CENGİZ SEVAL, G., CİVRİZ BOZDAĞ, S., YÜKSEL, M., TOPRAK, S. K., Topcuoglu, P., & Beksac, M., (2018). Ruxolitinib in steroid refractory GVHD treatment: single center experience . 44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) (pp.448-449). Lisbon, Portugal

CENGİZ SEVAL, GÜLDANE Et Al. "Ruxolitinib in steroid refractory GVHD treatment: single center experience," 44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 2018

CENGİZ SEVAL, GÜLDANE C. Et Al. "Ruxolitinib in steroid refractory GVHD treatment: single center experience." 44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) , Lisbon, Portugal, pp.448-449, 2018

CENGİZ SEVAL, G. Et Al. (2018) . "Ruxolitinib in steroid refractory GVHD treatment: single center experience." 44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) , Lisbon, Portugal, pp.448-449.

@conferencepaper{conferencepaper, author={GÜLDANE CENGİZ SEVAL Et Al. }, title={Ruxolitinib in steroid refractory GVHD treatment: single center experience}, congress name={44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT)}, city={Lisbon}, country={Portugal}, year={2018}, pages={448-449} }